| Dr. Kohkan Shamsi |
| |
 |
| |
| Dr. Shamsi brings extensive experience in Drug Development
of diagnostic agents and Bio-imaging markers in clinical trials.
He has worked in leadership positions in Diagnostic Imaging
Strategic Business Unit at Schering AG, Berlin, Germany and
in the Diagnostic Imaging and Radiopharmaceuticals Business
Unit, Clinical Operations and medical development at Berlex
Inc., NJ, USA. He has launched several products and has been
a thought leader with FDA and EU regulators in the last decade.
He has mentored the development of imaging-CRO's (I-CRO) in
this emerging field. |
| |
| Dr. Shamsi is an MD in Radiodiagnosis from Aligarh Muslim
University and a Ph.D from the University of Antwerp, Belgium.
Dr. Shamsi has published over 90 papers in indexed journals.
Dr. Shamsi has conceptualized, coordinated, and executed over
25 multi-center, international clinical trials (phase I -
phase III) to develop new contrast agents for oncology imaging,
CNS, Magnetic Resonance Angiography and cardiac imaging. He
has also submitted many NDAs in Europe, USA and Japan. |
| |
| Dr. Shamsi is a member of Radiological Society of North
America and International Society of Magnetic Resonance in
Medicine. He is also a member of North American Society of
Cardiac Imaging and Indian Radiology & Imaging Association
|
| |
| <
back |